Suicidal ideation — thoughts about ending one’s life — exists on a spectrum. For some people it is passive: a recurring wish not to be here, a sense that others would be better off without them, or a fantasy of escape from pain that feels unbearable and permanent. For others it is more active: intrusive thoughts about methods, plans, or timing. Both are serious. Both deserve clinical attention, not judgment.

Suicidal ideation is most commonly a symptom of an underlying condition, particularly major depressive disorder (MDD), treatment-resistant depression (TRD), PTSD, or a combination of these. It is the mind’s response to pain that has exceeded its capacity to cope, not a character flaw, not a moral failure, and not a fixed or inevitable state. With the right treatment, it can be addressed, and the conditions that give rise to it can change.

For many years, the clinical options for people experiencing suicidal ideation as part of MDD were limited: hospitalization, medication adjustment, and supportive therapy. Ketamine and Spravato have changed that picture meaningfully. Both have demonstrated the ability to reduce suicidal ideation rapidly, often within hours, offering a degree of acute relief that conventional antidepressants simply cannot provide on that timescale.

• Spravato (esketamine) is the only FDA-approved treatment specifically indicated for major depressive disorder with acute suicidal ideation or behavior.
• Ketamine has demonstrated rapid reduction in suicidal ideation in clinical research, often within hours of administration.
• Suicidal ideation is a symptom of treatable conditions, not an immutable state, and effective, evidence-based care exists.

At InnerMost, we treat suicidal ideation as a clinical symptom embedded in a larger picture: the depression, trauma, or accumulated burden that has brought a person to this point. Our goal is not only to reduce the acuity of suicidal thoughts in the short term but to address the underlying conditions that sustain them, with the full depth of integrated clinical care.

Our approach combines three elements: the rapid neurological action of Spravato or ketamine to provide acute relief; trauma-informed psychotherapy to address the psychological and relational roots of the suffering; and integration work to help what shifts during treatment become lasting change. We do not treat suicidal ideation as a crisis to be managed and discharged. We treat it as part of a person’s story, one that deserves to be understood and worked with over time.

Your InnerMost care team will determine the most appropriate treatment pathway during your initial consultation, taking into account your clinical history, current symptom severity, and overall presentation.

InnerMost provides ongoing clinical care for adults in Manhattan and across New York City who are experiencing suicidal ideation as part of a diagnosable mental health condition. We are not an emergency or crisis service. If you are in immediate danger, please call or text 988 or go to your nearest emergency room.

We work with adults who are:

• Experiencing passive or active suicidal ideation as part of major depressive disorder (MDD) or treatment-resistant depression (TRD)
• Managing suicidal thoughts that co-occur with PTSD, trauma, anxiety, or substance use disorder
• Stable enough to engage in outpatient care but looking for a more effective, integrated treatment approach than what they have tried before
• Currently on medication or in therapy but not finding adequate relief from suicidal ideation
• Looking for a clinical environment where they can speak openly about suicidal thoughts without fear of automatic hospitalization or judgment

We understand that one of the reasons people do not seek help for suicidal ideation is fear: fear of being hospitalized, fear of being labeled, fear that honesty will result in a loss of control over their own care. At InnerMost, we take a collaborative, patient-centered approach. Our goal is to provide the most effective outpatient care possible and to support your autonomy throughout the process. We will always prioritize your safety, and we will always be honest with you about when a higher level of care may be needed.

• Depression
• Anxiety Disorders
• Trauma & PTSD
• Substance Use Disorder
• Chronic Illness

Our integrated model addresses suicidal ideation on multiple levels simultaneously. Here is what the research and our clinical experience show:

Beginning treatment for suicidal ideation takes courage. Here is how the process typically unfolds at InnerMost, and what you can expect at each stage:

For people carrying the weight of suicidal ideation, walking into a clinical space can feel daunting. At InnerMost, our Manhattan center at 137 East 25th Street, 11th Floor, in the Nomad neighborhood was designed to feel nothing like the clinical environments that can make that weight heavier. Calming materials, private treatment rooms, and an atmosphere of safety and containment: every detail was chosen with the nervous system in mind.

You will not be met with clipboards, cold lighting, or clinical distance. You will be met by people who understand the depth of what you are carrying and who are here to help you carry it differently.

Our center is easily accessible from Midtown, Flatiron, Gramercy, Chelsea, and the East Village. Telehealth consultations are also available for New York residents.

We believe cost should not be a barrier to accessing care for suicidal ideation. Here’s what you need to know:

If you are in Manhattan or anywhere in New York City and living with suicidal ideation, reaching out takes courage. We want you to know that effective treatment exists, that what you are experiencing is not permanent, and that InnerMost is a place where you will be met with the care and clinical depth your situation deserves. Schedule a free discovery call with an InnerMost care coordinator. There is no judgment, no obligation, and no pressure. We are here to listen, and we are here to help.